Webpackaging logo

Innovative Syringe Label: Pharma-Multi-Act Combines Cleverly Designed Marking with Practical First-Opening Protection

Europe, Pharmaceuticals, Primary Packaging, Caps, Lids, Easy-Open Closures, Closure Components, Seals, Secondary Packaging, Labels, Shows, Associations, Media, Packaging Trade Shows, Events, Interpack

Schreiner MediPharm has developed a novel marking solution for syringes: Pharma-Multi-Act. The label, together with the cap, is easy to open with one flick of the wrist, which makes it particularly user-friendly. Pharma-Multi-Act also offers reliable and irreversible first-opening indication and may include various additional security and indicator functionalities. At interpack in Düsseldorf from May 4 to 10, 2017, Schreiner MediPharm will be presenting the wide range of possibilities offered by the label’s special design as part of its lineup of innovative solutions in Hall 7A, Booth B02.

Pharma-Multi-Act by Schreiner MediPharm has a unique feature: a label-integrated perforated tab that ends on the syringe cap. The marking label’s first-opening indication is automatically triggered along the perforation when opening the cap. As a result, the label and the container are opened at the same time by a single flick of the wrist, without requiring another step to remove the seal. 

Syringes require special tamper protection solutions that can be activated fast and effectively without impairing the injection process: the fewer moves needed and the simpler the activation, the better. In many cases, it is also necessary to document the administered medicine in the patient’s file or vaccination card. 

In the process of opening Pharma-Multi-Act, a readily accessible, detachable documentation label is exposed on the cap, which can be easily peeled off even with gloves. In addition, the area underneath the detachable label can be used as an indicator field for various functions. Examples range from an initially covert warning message, an additional security feature for authentication, an integrated NFC chip for interactive applications through to a temperature or UV indicator that is activated by opening the label.

For additional information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group GmbH & Co. KG
Bruckmannring 22
85764 Oberschleissheim
Germany
Phone +49 89 31584-5400
Fax +49 89 31584-5422
info@schreiner-medipharm.com
www.schreiner-medipharm.com

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Company News
  • English
  • Modified 18 May 2017
  • Hits 351